scispace - formally typeset
T

Taro Iguchi

Researcher at Osaka City University

Publications -  52
Citations -  1113

Taro Iguchi is an academic researcher from Osaka City University. The author has contributed to research in topics: Prostate cancer & Enzalutamide. The author has an hindex of 13, co-authored 45 publications receiving 593 citations.

Papers
More filters
Journal ArticleDOI

ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer

TL;DR: Enzalutamide with ADT significantly reduced the risk of metastatic progression or death over time versus placebo plus ADT in men with mHSPC, including those with low-volume disease and/or prior docetaxel, with a safety analysis that seems consistent with the safety profile of enzalutamia in previous clinical trials in castration-resistant prostate cancer.
Journal ArticleDOI

Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer

TL;DR: In conclusion, enzalutamideplus ADT significantly prolongs survival versus placebo plus ADT in patients with mHSPC, and adverse events were generally consistent with previous reports of long-term enzalUTamide use.
Journal ArticleDOI

Desensitization protocol in highly HLA-sensitized and ABO-incompatible high titer kidney transplantation.

TL;DR: The findings suggest that the immunosuppression regimen consisting of rituximab infusions, splenectomy, plasmapheresis, and pharmacologic immunOSuppression may prove to be effective as a desensitization protocol for highly HLA-sensitized and ABO-incompatible high-titer kidney transplantation.